Effectiveness of CGA on QoL in Older Patients With Cancer Receiving Systemic Therapy

NCT04069962 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 204

Last updated 2023-03-29

No results posted yet for this study

Summary

The G-oncoCOACH study aims to evaluate the effectiveness of the Comprehensive Geriatric Assessment (CGA) process coordinated by a geriatric team in combination with intensive patient coaching compared to the current standard of care, which is CGA coordinated by an oncology team.

Conditions

  • Geriatrics
  • Comprehensive Geriatric Assessment

Interventions

BEHAVIORAL

CGA coordination by geriatric team including intensive patient coaching and follow-up

In the intervention group, the CGA including geriatric recommendations for interventions will be coordinated by the geriatric team and will be complemented with patient coaching. This intervention aims to support patient empowerment by improving self-efficacy and supporting self-management of existing age-related problems before systemic therapy or occurring during systemic therapy, and includes an individual counselling session at start of systemic therapy to discuss the recommendations with the patient and to determine their priorities.

Sponsors & Collaborators

  • Kom Op Tegen Kanker

    collaborator OTHER
  • Universitair Ziekenhuis Brussel

    collaborator OTHER
  • Universitaire Ziekenhuizen KU Leuven

    lead OTHER

Principal Investigators

  • Hans Wildiers, prof. dr. · adjunct head of clinic

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-30
Primary Completion
2022-12-31
Completion
2023-03-25

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04069962 on ClinicalTrials.gov